J. Maul

发表

Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations

J. Maul, M. Zeitz, 2011, Langenbeck's Archives of Surgery.

Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level.

H. Stein, C. Loddenkemper, J. Maul, 2006, European journal of immunology.

Modulation of systemic antigen‐specific immune responses by oral antigen in humans

J. Maul, M. Zeitz, A. Thiel, 2010, European journal of immunology.

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

J. Maul, A. Schoepfer, G. Moran, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding: Results of a Prospective Multicenter Observational Pilot Study

J. Maul, B. Wiedenmann, J. Preiß, 2016, Journal of clinical gastroenterology.

Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.

J. Maul, A. Schoepfer, G. Moran, 2010, Journal of Crohn's & colitis.

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

E. Louis, Y. Yazdanpanah, J. Maul, 2011, Gut.

Preexisting antigen‐specific immune responses are modulated by oral KLH feeding in humans

J. Maul, A. Thiel, J. Preiß, 2015, European journal of immunology.

Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease

J. Maul, F. Marzinzik, J. Preiß, 2018, International journal of colorectal disease.

Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series

J. Maul, N. Teich, A. Stallmach, 2017, Inflammatory Intestinal Diseases.

Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can be Used to Predict Response of Patients With Inflammatory Bowel Diseases to Infliximab.

J. Maul, A. Kühl, R. Glauben, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans

A. Scheffold, S. Brunke, J. Maul, 2019, Cell.

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

T. Giese, C. Loddenkemper, J. Maul, 2005, Gastroenterology.

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

J. Maul, A. Schoepfer, S. Vavricka, 2018, Journal of Crohn's & colitis.

Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.

H. Stein, C. Loddenkemper, J. Maul, 2006, Blood.

Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis

T. Kohlmann, E. Weber, J. Maul, 2013, BMC Gastroenterology.

Can loss of immune tolerance cause IBD?

J. Maul, R. Duchmann, 2008, Inflammatory bowel diseases.

Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome.

C. Loddenkemper, S. Ehl, J. Maul, 2012, Gastroenterology.

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

J. Maul, M. Scheurlen, D. Strobel, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Mo1334 Reasons for the Delay of Diagnosis in Inflammatory Bowel Disease

J. Maul, B. Wiedenmann, J. Preiß, 2013 .

A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients

A. Scheffold, J. Maul, A. Kühl, 2022, Mucosal Immunology.

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study

J. Hampe, J. Maul, R. Atreya, 2016, Alimentary pharmacology & therapeutics.

Colitis ulcerosa

J. Maul, M. Zeitz, Dr. J. Maul, 2012, coloproctology.

Simultaneous Presence of Non- and Highly Mutated Keyhole Limpet Hemocyanin (KLH)-Specific Plasmablasts Early after Primary KLH Immunization Suggests Cross-Reactive Memory B Cell Activation

Andreas Radbruch, J. Maul, A. Thiel, 2018, The Journal of Immunology.

Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study.

C. Loddenkemper, J. Maul, J. Preiß, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[Chronic inflammatory bowel diseases: state of the art].

J. Maul, B. Siegmund, 2014, Deutsche medizinische Wochenschrift.

Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study.

F. Lammert, S. Brand, J. Maul, 2014, Journal of Crohn's & colitis.

Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life

J. Maul, F. Marzinzik, J. Preiß, 2016, International Journal of Colorectal Disease.

Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease

A. Scheffold, A. Franke, S. Brunke, 2023, Nature Medicine.

Can loss of immune tolerance cause IBD?

J. Maul, R. Duchmann, 2008, Inflammatory bowel diseases.

To the Editor – Eur. J. Immunol. 1/2006

H. Stein, C. Loddenkemper, J. Maul, 2006 .

Chronisch entzündliche Darmerkrankungen: State of the Art

J. Maul, B. Siegmund, 2014, Deutsche Medizinische Wochenschrift.